IP Library Granted Patent US 7,534,568
Granted Patent B2
US 7,534,568 · App. 11/607,341 · Granted May 19, 2009

Methods for detection of a target nucleic acid by forming a cleavage structure with a cleavage resistant probe

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,534,568
App. No.
11/607,341
Granted
May 19, 2009
Kind
B2
Abstract

The invention relates to compositions and methods for generating a signal indicative of the presence of a target nucleic acid in a sample utilizing a cleavage resistant probe.

Claims (81)

1. A composition comprising a polymerase, a cleavage agent, an upstream primer and a downstream cleavage resistant probe, wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by said cleavage agent upon formation of an overlapping structure and said cleavage susceptible portion is susceptible to cleavage by said cleavage agent upon formation of a non-overlapping cleavage structure, and wherein the cleavage resistant probe comprises a segment complementary to a target, the 5′-terminal position of said segment being designated the +1 position, and the position 3′ to the +1 position being designated the +2 position.

2. The composition of claim 1 , wherein said cleavage resistant portion comprises one or more modifications that renders the portion downstream of the +1 position not susceptible to cleavage.

3. The composition of claim 1 , wherein said cleavage resistant probe comprises one or more modifications that renders the portion downstream of the +2 position not susceptible to cleavage.

4. The composition of claim 1 , wherein said cleavage resistant probe has a stretch of two or more thymidines upstream and contiguous to the +1 position.

5. The composition of claim 1 , wherein said cleavage resistant probe has a stretch of three or more thymidines upstream and contiguous to the +1 position.

6. The composition of claim 2 , wherein said modification is a thiophosphate.

7. The composition of claim 2 , wherein said modification is 2′-O-methoxy.

8. The composition of claim 1 , wherein said cleavage resistant probe comprises at least one labeled moiety capable of providing a signal.

9. The composition of claim 1 , wherein said cleavage resistant probe comprises a pair of interactive signal generating labeled moieties effectively positioned to quench the generation of a detectable signal, the labeled moieties being separated by a site susceptible to FEN nuclease cleavage.

10. The composition of claim 9 , wherein the pair of interactive signal generating moieties comprises a quencher moiety and a fluorescent moiety.

11. The composition of claim 9 , wherein said pair of interactive signal generating moieties are effectively positioned to separate upon cleavage of a non-overlapping cleavage structure.

12. The composition of claim 11 , wherein a first member of said pair of interactive signal generating moieties is operatively coupled to the +1 position and a second member of said pair of interactive signal generating moieties is operatively coupled to a 5′ flap.

13. The composition of claim 1 , further comprising an upstream oligonucleotide which is complementary to the same region of the target as the primer and comprises at least one 3′ terminal nucleotide which is non-complementary to the target.

14. The composition of claim 1 , further comprising an upstream oligonucleotide which is complementary to a region of the target that is upstream and adjacent of the region of the target that is complementary to the downstream cleavage resistant probe.

15. The composition of claim 1 , further comprising a reverse primer.

16. The composition of claim 1 , wherein said polymerase substantially lacks 5′ to 3′ nuclease activity.

17. The composition of claim 1 , wherein said cleavage agent comprises a 5′ nuclease.

18. The composition of claim 17 , wherein said 5′ nuclease is a FEN-1 nuclease.

19. The composition of claim 18 , wherein said FEN-1 nuclease is a flap specific nuclease.

20. The composition of claim 18 , wherein said FEN-1 nuclease is thermostable.

21. The composition of claim 1 , wherein said polymerase is thermostable.

22. The composition of claim 1 , wherein the 3′ nucleotide of said cleavage resistant probe has a blocking group.

23. A composition comprising a polymerase, a cleavage agent, an upstream oligonucleotide and a downstream cleavage resistant probe, wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion and said upstream oligonucleotide has at least one 3′ terminal nucleotide which is non-complementary to a target, wherein said cleavage resistant portion is not susceptible to cleavage by said cleavage agent upon formation of an overlapping structure and said cleavage susceptible portion is susceptible to cleavage by said cleavage agent upon formation of a non-overlapping cleavage structure.

24. A kit comprising the composition of claim 1 and packaging materials therefore.

25. A composition comprising:

(i) a cleavage agent

(ii) a target nucleic acid, which comprises in 3′ to 5′ order a first region, an extension region, and a second region;

(iii) an upstream primer that is at least partially complementary to said first region of said target nucleic acid;

(iv) a downstream cleavage resistant probe comprising a 5′ region and a 3′ region, wherein said 3′ region is at least partially complementary to said second region of said target nucleic acid and wherein said 5′ region is not complementary to said target nucleic acid, said cleavage resistant probe also includes a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by said cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by said cleavage agent upon formation of a non-overlapping cleavage structure; and

(v) a polymerase.

26. A composition comprising:

(i) a cleavage agent

(ii) a target nucleic acid, which comprises in 3′ to 5′ order a first region, an extension region, and a second region;

(iii) an upstream oligonucleotide that is at least partially complementary to said first region of said target nucleic acid and comprises at least one 3′ terminal nucleotide which is non-complementary to the target,

(iv) a downstream cleavage resistant probe comprising a 5′ region and a 3′ region, wherein said 3′ region is at least partially complementary to said second region of said target nucleic acid and wherein said 5′ region is not complementary to said target nucleic acid, said cleavage resistant probe also includes a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by said cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by said cleavage agent upon formation of a non-overlapping cleavage structure; and

(v) a polymerase.

27. A method of generating a signal indicative of the presence of a target nucleic acid sequence in a sample, comprising forming a cleavage structure by incubating a sample comprising a target nucleic acid sequence with a polymerase, an upstream primer and cleavage resistant probe, wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by said cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by said cleavage agent upon formation of a non-overlapping cleavage structure and cleaving the cleavage structure at a position in said probe that is susceptible to cleavage with a cleavage agent to generate a signal, wherein generation of the signal is indicative of the presence of a target nucleic acid sequence in the sample.

28. A method of generating a signal indicative of the presence of a target nucleic acid sequence in a sample, comprising forming a cleavage structure by incubating a sample comprising a target nucleic acid sequence with a polymerase, an upstream oligonucleotide and cleavage resistant probe, wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion and said upstream oligonucleotide has at least one 3′ terminal nucleotide which is non-complementary to a target, wherein said cleavage resistant portion is not susceptible to cleavage by said cleavage agent upon formation of an overlapping structure and said cleavage susceptible portion is susceptible to cleavage by said cleavage agent upon formation of a non-overlapping cleavage structure and cleaving the cleavage structure at a position in said probe that is susceptible to cleavage with a cleavage agent to generate a signal, wherein generation of the signal is indicative of the presence of a target nucleic acid sequence in the sample.

29. A method of detecting or measuring a target nucleic acid sequence, comprising forming a cleavage structure by incubating a sample comprising a target nucleic acid sequence with a polymerase, an upstream primer and cleavage resistant probe and cleaving the cleavage structure at a position in said probe that is susceptible to cleavage with a cleavage agent to release a nucleic acid fragment and detecting and/or measuring the release of the fragment as an indication of the presence of the target sequence in the sample.

30. A method for detecting a target nucleic acid sequence in a sample comprising: mixing

a cleavage agent,

an upstream primer,

a downstream cleavage resistant probe, wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by said cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by said cleavage agent upon formation of a non-overlapping cleavage structure,

a polymerase, and

a target nucleic acid

under conditions which are permissive for the steps of (i) annealing of the upstream primer and downstream cleavage resistant probe, (ii) extending the upstream primer wherein the polymerase synthesizes a primer extension product and forms a cleavage structure with the downstream cleavage resistant probe, and (iii) cleaving the cleavage structure with the cleavage agent to generate a detectable signal and detecting and/or measuring the signal.

31. The method of claim 30 , wherein the downstream cleavage resistant probe comprises a 5′ region and a 3′ region wherein the 3′ region is at least partially complementary to the target nucleic acid and the 5′ region forms a flap.

32. A method of detecting a target nucleic acid, comprising:

(a) providing:

an upstream primer that is at least partially complementary to a first region of a target nucleic acid, and

a downstream cleavage resistant probe comprising a 5′ region and a 3′ region, wherein the 3′ region is at least partially complementary to a second region of the target nucleic acid and wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by a cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by the cleavage agent upon formation of a non-overlapping cleavage structure;

(b) mixing the target nucleic acid and the upstream primer and downstream cleavage resistant probe under conditions which permit formation of a duplex between the target nucleic acid and the upstream primer and the 3′ region of the downstream cleavage resistant probe;

(c) subjecting the duplex to a polymerase activity under conditions which permit extension of the upstream primer by polymerization of a nucleic acid strand complementary to a length of the extension region sufficient to form a cleavage structure;

(d) providing a cleavage agent under conditions such that cleavage of the cleavage structure occurs at a site located within the downstream cleavage resistant probe in a manner dependent upon the formation of the cleavage structure, thereby permitting cleavage of the downstream cleavage resistant probe;

(e) detecting the cleavage of the downstream cleavage resistant probe.

33. The method of claim 32 , wherein the polymerase activity polymerizes nucleotides complementary to a length of extension region sufficient to form a cleavage structure, the polymerized complementary nucleic acid is adjacent at its 3′ end to the downstream oligonucleotide in the duplex.

34. The method of claim 32 , wherein the polymerase activity polymerizes nucleotides complementary to a length of extension region sufficient to form a cleavage structure, the length of the extension region is a length such that the extension region is fully duplex nucleic acid.

35. The method of claim 32 , wherein the 5′ region of the downstream cleavage resistant probe forms a 5′ flap.

36. A method of detecting a target nucleic acid, comprising:

(a) providing:

an upstream primer that is at least partially complementary to a first region of a target nucleic acid,

an upstream oligonucleotide that is at least partially complementary to an extension region of the target nucleic acid and comprises at least one 3′ terminal nucleotide which is non-complementary to the target, and

a downstream cleavage resistant probe comprising a 5′ region and a 3′ region, wherein the 3′ region is at least partially complementary to a second region of the target nucleic acid and wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by a cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by the cleavage agent upon formation of a non-overlapping cleavage structure;

(b) mixing the target nucleic acid, the upstream primer, upstream oligonucleotide and downstream cleavage resistant probe under conditions which permit formation of a duplex between the target nucleic acid and the upstream primer, the upstream oligonucleotide and the 3′ region of the downstream cleavage resistant probe;

(c) subjecting the duplex to a polymerase activity and cleavage activity under conditions which permit extension of the upstream primer and cleavage of the cleavage resistant probe; and

(d) detecting the cleavage of the downstream cleavage resistant probe.

37. A method of detecting a target nucleic acid, comprising

(a) providing:

a target nucleic acid, which comprises in 3′ to 5′ order a first region and a second region,

a template nucleic acid, which comprises in 3′ to 5′ order a first region and a second region,

a first upstream oligonucleotide that is at least partially complementary to said first region of said target nucleic acid,

a first cleavage resistant probe comprising a 5′ region and a 3′ region, wherein said 3′ region is complementary to said second region of said target nucleic acid and wherein said 5′ region is not complementary to said target nucleic acid but is at least partially complementary to said first region of said template nucleic acid, and wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by a cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by the cleavage agent upon formation of a non-overlapping cleavage structure;

a second cleavage resistant probe comprising a 5′ region and a 3′ region, wherein said 3′ region is at least partially complementary to said second region of said template nucleic acid and said 5′ region is not complementary to said template nucleic acid, and wherein said cleavage resistant probe comprises a cleavage resistant portion and a cleavage susceptible portion, wherein said cleavage resistant portion is not susceptible to cleavage by a cleavage agent upon formation of a overlapping structure and said cleavage susceptible portion is susceptible to cleavage by the cleavage agent upon formation of a non-overlapping cleavage structure;

a cleavage agent, and

a nucleic acid polymerase;

(b) mixing said target nucleic acid, said template nucleic acid, said first said first upstream oligonucleotide, cleavage resistant probe, said second cleavage resistant probe, said cleavage agent and said nucleic acid polymerase under reaction conditions, wherein said reaction conditions permit;

forming a duplex between said target nucleic acid and each of said first upstream oligonucleotide and said first cleavage resistant probe, wherein the 5′ region of the first cleavage resistant probe forms a first flap of a first cleavage structure,

cleaving the first flap by said cleavage agent, thereby permitting release of the first flap,

forming a second duplex with the released first flap, said template nucleic acid, and said second cleavage resistant probe, wherein the 5′ region of said second cleavage resistant probe forms a second flap of a second cleavage structure, and

cleaving the second flap by said cleavage agent; and

(c) detecting a signal generated from the cleaving of the second flap.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →